» Authors » Yoshimitsu Fukushima

Yoshimitsu Fukushima

Explore the profile of Yoshimitsu Fukushima including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 148
Citations 5478
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawai T, Kinoshita S, Takayama Y, Ohnishi E, Kamura H, Kojima K, et al.
Genet Med Open . 2024 Dec; 2:101838. PMID: 39669601
Purpose: Wolf-Hirschhorn syndrome (WHS), a contiguous gene syndrome caused by heterozygous deletions of the distal short arm of chromosome 4 that includes , reportedly causes specific DNA methylation signatures in...
2.
Atsumi K, Fukushima Y, Tanaka Y, Nishima S, Tanaka T, Seike M, et al.
Pulm Circ . 2024 Aug; 14(3):e12423. PMID: 39170759
In pulmonary hypertension (PH) associated with chronic lung disease (CLD), identifying patients who would benefit from pulmonary vasodilators is a significant clinical challenge because the presence of PH is associated...
3.
Yoshida S, Nakata T, Naya M, Momose M, Taniguchi Y, Fukushima Y, et al.
Circ Rep . 2023 Jun; 5(6):252-259. PMID: 37305793
Definitions of cardiac sarcoidosis (CS) differ among guidelines. Any systemic histological finding of CS is essential for the diagnosis of CS in the 2014 Heart Rhythm Society statement, but not...
4.
Kirinoki-Ichikawa S, Takagi G, Fukushima Y, Tara S, Miyamoto M, Kumita S
Wound Repair Regen . 2023 Mar; 31(3):384-392. PMID: 36866489
Standard non-invasive methods for diagnosing and selecting the best treatment for osteomyelitis in patients with multiple chronic conditions remain to be established. We aimed to evaluate the ability of quantitative...
5.
Nakata T, Nakajima K, Naya M, Yoshida S, Momose M, Taniguchi Y, et al.
Ann Nucl Cardiol . 2022 Dec; 8(1):42-50. PMID: 36540169
: Recent advances in cardiac modalities contribute to the guidelines on the diagnosis of cardiac sarcoidosis (CS) updated by the Japanese Circulation Society. The multicenter registry, Japanese Cardiac Sarcoidosis Prognostic...
6.
Nishikawa Y, Fukushima Y, Kirinoki S, Takagi G, Suda M, Maki T, et al.
Eur J Hybrid Imaging . 2022 Nov; 6(1):27. PMID: 36450868
Background: Patients with lower-limb osteomyelitis (LLOM) may experience major adverse events, such as lower-leg amputations or death; therefore, early diagnosis and risk stratification are essential to improve outcomes. Ga-scintigraphy is...
7.
Yodogawa K, Fukushima Y, Tachi M, Fujimoto Y, Hagiwara K, Oka E, et al.
Int Heart J . 2022 Mar; 63(2):235-240. PMID: 35354745
Sustained ventricular tachycardia (sVT), leading to sudden cardiac death, is one of the common manifestations in cardiac sarcoidosis (CS). Although late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) has...
8.
Morishima M, Kiriyama T, Miyagi Y, Otsuka T, Fukushima Y, Kumita S, et al.
Ann Nucl Med . 2021 Dec; 36(3):255. PMID: 34902097
No abstract available.
9.
Nishizawa H, Motobayashi M, Akahane M, Wakui K, Kitazawa N, Inaba Y, et al.
Brain Dev . 2021 Dec; 44(3):229-233. PMID: 34876316
Background: Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR) syndrome is a contiguous gene deletion syndrome caused by a de novo deletion including the 11p13 region. Although autism spectrum...
10.
Morishima M, Kiriyama T, Miyagi Y, Otsuka T, Fukushima Y, Kumita S, et al.
Ann Nucl Med . 2021 Nov; 36(3):244-254. PMID: 34822103
Objective: Myocardial ischemia is known to suppress fatty acid metabolism and favor glucose metabolism. However, changes in myocardial metabolism after coronary revascularization are not fully elucidated. Methods: Thirty-eight patients with...